chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first 2 days sore arm, but starting 3rd day; high fever over 104, alternating sweats and chills, general weakness; has lasted for 6 days now and still unable to get up for more than 5 minutes. (not sure if within normal range of expected, but neither if the second dose is advised).
Vaccine administered 10/26/16 (L) deltoid. 12 hrs after developed redness, swelling, pain, itching. At 48 hrs post vaccine0redness neck to elbow (L) arm. At 55 hrs post vaccine-redness midline chest. Neck and LUE to elbow. Reports low grade fever.
Red raised welt at injection site that is warm to touch.  Welt has approximately 5 inch diameter.
Broke out wit a terrible case of chicken pox. Missed her first week and a half of school. All children in the family was given the Varivax on the same day and all ended up with chicken pox.
pt became diaphoretic, pale w/oral cyanosis;c/o nausea & vertigo;MD monitored VS p/10min;pt color improved p/20min;pt color improved;pulse inc to 100;
Itchy red rash all over torso in 2nd to 3rd day. Congestion and repeatedly sneezing until my nose is red on 5th day. I have had similar respiratory issues in past but, usually it's something I've breathed in the air. I've been taking Benedryl around the clock and keeping it to myself. Just thought you should know.
Tender deltoid, right side, no significant- (erythema medial tricep), heal or effusion.
INFLAMMATION ON LEGS; ACHES/SEVERE SHARP PAIN ALL OVER BODY; UNCONTROLLABLE SHAKES; VOMITING; FEVER; HEADACHE; MUSCLE ACHE; This spontaneous report received from a consumer concerned a 25 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19, and concurrent conditions included asthma, hypertension, immune system problems, achalasia., chocolate intolerant, and lactose intolerant. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 14:00 for prophylactic vaccination. Concomitant medications included nifedipine for hypertension. On APR-2021, the subject experienced muscle ache. On 12-APR-2021, the subject experienced uncontrollable shakes. On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. On 12-APR-2021 22:00, the subject experienced aches/severe sharp pain all over body. On 13-APR-2021, the subject experienced inflammation on legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from uncontrollable shakes, and vomiting on 12-APR-2021, had not recovered from aches/severe sharp pain all over body, inflammation on legs, and headache, and the outcome of fever and muscle ache was not reported. This report was non-serious.
Fully vaccinated and boosted. Asymptomatic COVID infection prior to admit for planned csection of full term baby. Baby girl,   Born (Privacy) at 39 w gestation   8#11 oz. Babys MD (Privacy), MD   Moms MD (Privacy), MD
Received flu vaccine 11/5/13. C/o sore arm (right) and swelling at base of neck her right clavicle on 11/6/13 at 6 pm. Afebrile. Saw her PMD and dx with vaccine reaction and PMD ordered cxr.
She had some itching at elbows with first dose, resolved at time within  a few minutes was given loratadine x 1 after resolved.  Checked with MD okay to receive with antihistamine Given Loratadine prior to second vaccine.   Vaccine given at 08:20  started with raised wheal left arm approx 30 minutes  post vaccine.   Then started on back and left elbow.   Activated EMS system.  Gave Benadryl 25 MG.  Vitals 140/90 98%  75.   HR decreased to 66 94% O2    epipen.3mg given x 1.  Paramedics arrived.   O2 sat improved to 98 % ,  was transferred to  for further evaluation.
FATIGUE; HEADACHE; FEVER; This spontaneous report received from a parent concerned a 20 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 23-JUL-2021 at 11:30 for prophylactic vaccination. No concomitant medications were reported. On 23-JUL-2021, the subject experienced fatigue. On 23-JUL-2021, the subject experienced headache. On 23-JUL-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102. Treatment medications (dates unspecified) included: dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, headache, and fever. This report was non-serious.
off balance; shaking; feels like panic attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Sep2021 11:00 (Lot number: ep7533) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Blood pressure. The patient took concomitant medications. Vaccination history included: Bnt162b2 ({product=COVID 19, brand=pfizer, ew0176, lot number=pfizer biontech,, lot unknown=False,, administration date=14Aug2021,, administration time=10:00 AM,, dose number=1,, vaccine location=Right arm}]), administration date: 14Aug2021, when the patient was 58 years old, for covid-19 immunization. The following information was reported: BALANCE DISORDER (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "off balance"; TREMOR (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "shaking"; PANIC ATTACK (non-serious) with onset 11Sep2021 11:15, outcome "not recovered", described as "feels like panic attack". Therapeutic measures were not taken as a result of balance disorder, tremor, panic attack. No follow-up attempts are possible. No further information is expected.
Information has been received from an LPN concerning a 17 year old male pt who in 1986 was vaccinated with a 1st dose of MMRII. Subsequently, the pt developed multiple sclerosis. The pt's multiple sclerosis persisted. Unspecified medical attention was sought. Upon internal review, multiple sclerosis was determined to be an "Other Important Medical Event". Additional information has been requested. FOLLOW-up information received indicated that the patient did not have a reacion, and that their concern was "could there be." No further information is available.
C/O dizziness and headache.MD recommended PO hydration, elevate lower extremities and continue to monitor. Continued monitoring and member felt better. Declined ACC evaluation
INJECTION SITE SORENESS; This spontaneous report received from a consumer concerned a 60 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced injection site soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injection site soreness was not reported. This report was non-serious. This case, from the same reporter is linked to 20210503868.
This spontaneous report as received from a physician refers to a 12 months old female patient. The patient was vaccinated into right thigh with first standard dose of VARIVAX (merck) (lot # H016057, expired date unspecified) on 03-JAN-2013. No other co-suspects were reported. Concomitant medications included PREVENAR into left thigh and PREVNAR into left thigh. On 14-JAN-2013 the patient experienced a 101 degree fever and a slight cold with runny nose. The patient sought treatment with her HCP on 15-JAN-2013 the patient experienced a 101 degree fever and a slight cold with runny nose. The patient sought treatment with her HCP on 15-JAN-2013. The patient was recovering at the time of the reported. The relatedness for a 101 degree fever and a slight cold with runny nose was unknown for VARIVAX (Merck). Additional information is not expected.
Blistering around smallpox site, armpit swollen and sore, tingling in left hand.  Multiple bumps on back of head, neck, both arms, chest, finger, and back.  Pt presented to the clinic with chest pain 09 May 11.  EKG was performed to r/u myocarditis/pericarditis.  EKG did not show any signs of either condition.  Chest pain may have been due to anxiety related to Dx of generalized vaccinia.
Rash on left arm and leg; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on left arm and leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced RASH (Rash on left arm and leg). At the time of the report, RASH (Rash on left arm and leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pfizer-BioNTech COVID-19 Vaccine EUA He had Injection site swelling the same day of the vaccine. He had mild fever for 36 hrs days since the day of the vaccine. The most bothering side effect has been the swollen lymph nodes in the left arm (injection site). It has been two days since the vaccine day and it is still swollen and painful.
Patient felt light headed and feeling of warmth . As she sat there she progressively felt better. She did complain of some cramping. She said she was better and well enough to leave . I encouraged her to go to her primary care doctor or urgent care  if any symptoms persisted .
Client received Td vaccine at 0857 in the right arm. Client stated he was fine. At 0900 client received TST in left arm. Client stated, " everything is going black," and fainted.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-MAY-2015, the patient was vaccinated with an expired dose of ROTATEQ (oral, the first dose in series, dose unknown, lot # J010966, expiration date 20-MAR-2015). No adverse effect was reported. Additional information has been requested.
Began getting sore around bedtime on 2/8/17 left arm has red, swollen, painful area.
She felt dizzy after receving her 2nd dose of Janssen. She drink cold water and felt better and was monitored for 30minutes. The patient stated she had a similar experience( worst )with her first dose.
Information has been received from a pharmacist concerning a 47 year old female with a ppd allergy who on 08/06/04 was vaccinated with a second dose of hepatitis B virus vaccine rHBsAg (yeast) (lot # 646867/0179P). No other vaccinations were given at the same time. On 08/07/04, "within 2 to 4 hours of vaccination", the patient developed a headache, back and neck aches, rash nausea, vomiting, sores on her tongue and myalgia. She was treated with Ativan, Compazine, Toradol, Lortab. It was reported that the injection was not given in her deltoid, but slightly below the muscle. The injection site bled for a while. Unspecified medical attention was sought. The patient was considered not recovered. No product quality complaint was involved. Additional information has been requested.
Left arm (where received IPV/DTaP) swelling erythema (to purple color) tense from shoulder to elbow cellulitis local
High fever, migraine, dizziness, lightheaded, chills and sweats. Much worse than the 2nd shot. This was my booster
Within 2 hours, post vax, pt developed swelling of the face and hives appeared on her body. The pt was attending school. The school nurse notified her mother and told her to give the child Benadryl. The child was given 50mg of Benadryl and the swelling and rash had subsided when seen. No swelling or hives were observed. This pt's male sibling had the same vaccine that day also but had no reaction. Mother is allergic to eggs and strawberries.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021 at 3:10 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 4:20 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was reported as 27.61 on 14-Feb-2021 and 27.73 on 27-Mar-2021.  Concomitant products were not provided.  On 27-Mar-2021, Excursion time was 09 AM, temperature was 35 and at 10 AM temperature was 35, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  On 14-Feb-2021, Excursion time was 09 AM, temperature was 32, at 10 AM temperature was 32, at 11 AM temperature was 32, at 2 PM temperature was 35 and at 3 PM temperature was 35, total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 9-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Pain, swelling and bruising around the injection site in the deltoid muscle area of my left arm.  This was a booster shot.  The person that injected the shot pinched the area before and during the injection.  In the first two pfizer covid injections there was no pain, no swelling , no pinching and no bruising afterwards. The first two pfizer covid injections was performed by different person(s).
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 27-NOV-2013 the patient was vaccinated with GARDASIL (lot # was reported as 0840AA, Exp 14-OCT-2013), 0.5 ml, intramuscular that expired on 14-OCT-2013. No adverse effects were reported. It was unknown if the patient had sought medical attention. Additional information has been requested.
Pt had severe pain in injection site and body ache on the same day. She stated that she lost the range of motion and throbbing pain that lasted several wks. It has gotten better but still in pain I will go see MD.
was "almost like cellulitis."; arm "turned beet red"; This is a spontaneous report from a contactable consumer reported for her friend. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  he patient reported "almost like cellulitis" (medically significant) on an unspecified date with outcome of unknown ,and arm "turned beet red"  on an unspecified date with outcome of unknown.   Information on the lot/batch number has been requested.
arm became itchy; arm had a lump; dizziness; joint pain,a lot of joint pain.; redness around the injection site is large as a 1 dollar bill; head ache,such a bad head ache; sore at the injection site; a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever) and ARTHRALGIA (joint pain,a lot of joint pain.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (a low grade fever). On an unknown date, the patient experienced PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The additional concomitant drugs included thyroid medication.
I was diagnosed with COVID-19 ON 08/06/2021-COVID-19 Test- positive. The doctor was calling me once a week, and messaging me almost daily, and I had video appointments with him. Symptoms: having horrible headaches, lost sense of smell, chills, fatigue, body weakness, fever, really bad nausea, and a cough, and laryngitis. I had laryngitis for over a week. The doctor put me on Doxycycline. I wound up taking 2 doses from it, 14 days total. I was given Albuterol, Zofran for the nausea, and Excedrin for the headache, and taking my prescription medication when the Excedrin did not help. It would at least take the edge off of it but would not relieve it. I was also alternating Tylenol and Ibuprofen for my fever. I had my symptoms for like 45 days total.
Patient reported experiencing loss of bodily movement after reaching home from her vaccination. (waited in-store 20 minutes after receiving vaccine). Pt has fully recovered.
Client received one dose Janssen COVID vaccine lot #: 1822809 exp. 3/7/22 at Health Center (SRPHC). At 1550 after client received the Janssen vaccine, client reported to RN that he felt ?dizzy? and diaphoretic. RN took client?s vitals at 1550: blood pressure (BP) 117/70, Pulse (P) 68, oxygen saturation (O2) 91%, alert and oriented x 4 with pale and moist skin. At 1553, Lead RN transferred client to anti-gravity chair in a high fowler position and client drank water provided. Client reported to Lead RN he has a history of dizziness with blood draws. At 1555 RN took his vitals: BP 124/77, P 74, O2 98% and client reported no current symptoms. At 1558, client walked to observation to continue observation at the EMT station sitting in an anti-gravity chair in a high fowler position which he said ?I feel like when I came in.? At 1605 RN took client?s vitals: BP 117/81, P 84, O2 97% and client stated he had no more symptoms.  At 1621 RN took client?s vitals: 120/77, P 88, O2 98% which client stated he had no more symptoms and he felt ?normal.? Lead RN educated client about the signs and symptoms of adverse reactions and the need to seek EMS as needed. Client verbalized he understands. At 1621 client stood up unassisted in a steady gait and accompanied by his girlfriend who will drive them both home from the health center.